Unlike other nations, the US doesn't have centralized price caps. We pay for value but get hit by volume pricing on drugs and scans. Plus, our administrative complexity is unique: US doctors spend way more time on billing than their peers in Europe or Asia. It’s high-quality care, but at a massive, un-subsidized premium.